Moleculin Biotech
MBRX
MBRX
23 hedge funds and large institutions have $2.91M invested in Moleculin Biotech in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 6 closing their positions.
Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Squarepoint
New York
|
$23K |
| 2 |
HF
2
HRT Financial
New York
|
$15K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$30.6K |
| 4 |
TSS
4
Two Sigma Securities
New York
|
$13K |
| 5 |
5
Renaissance Technologies
New York
|
$91K |
